Home NDC 71687-3003 Pamprin Multi-Symptom
Product NDC 71687-3003
11-digit product format 716873003
Labeler code 71687
Product ID 71687-3003_4fe8f1cd-8250-e908-e063-6394a90a1173
Type HUMAN OTC DRUG
Nonproprietary name Acetaminophen, Pamabrom, Pyrilamine maleate
Dosage form TABLET
Route ORAL
Labeler Focus Consumer Healthcare, LLC
Application M013
Marketing category OTC MONOGRAPH DRUG
Marketing start 2016-06-01
Substance PYRILAMINE MALEATE; PAMABROM; ACETAMINOPHEN
Active strength 15; 25; 500 mg/1; mg/1; mg/1
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 21 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-04-01 02:39 UTC · source 2025-03-31 excluded product product I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 71687-3003-4 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 71687-3003-1 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 71687-3003-4 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 71687-3003-1 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 71687-3003-4 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 71687-3003-1 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 71687-3003-4 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 71687-3003-1 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product U Excluded because listing certification expired 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 71687-3003-4 U Excluded because listing certification expired 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 71687-3003-1 U Excluded because listing certification expired 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product U Excluded because listing certification expired ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 71687-3003-4 U Excluded because listing certification expired ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 71687-3003-1 U Excluded because listing certification expired ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product U Excluded because listing certification expired 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 71687-3003-4 U Excluded because listing certification expired 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 71687-3003-1 U Excluded because listing certification expired 0efc9e666f02…f202fb6c5f17…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Pamprin Multi-Symptom
Brand name suffix Maximum Strength
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength PYRILAMINE MALEATE 15 mg/1 PAMABROM 25 mg/1 ACETAMINOPHEN 500 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 3 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination R35D29L3ZA Internal UNII lookup UA8U0KJM72 Internal UNII lookup 362O9ITL9D Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1052637 Internal RxNorm lookup 1053852 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 71687-3003-1 Pamprin Multi-SymptomMaximum Strength 20 in 1 BOTTLE, PLASTIC TABLET 20 5 71687-3003-1 Pamprin Multi-SymptomMaximum Strength 1 in 1 CARTON TABLET 1 5 71687-3003-4 Pamprin Multi-SymptomMaximum Strength 1 in 1 CARTON TABLET 1 5 71687-3003-4 Pamprin Multi-SymptomMaximum Strength 40 in 1 BOTTLE, PLASTIC TABLET 40 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 71687-3003 PAMPRIN MULTI-SYMPTOM MAXIMUM STRENGTH (ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE) TABLET [FOCUS CONSUMER HEALTHCARE, LLC] 4 Current NDC, Legacy NDC, 4 package rows 20250416_60b3286d-5698-df50-e053-2991aa0afbe2.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 54 of 79 · 1,579 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join NOTTS - Pain Relief PM ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE VIVUNT PHARMA LLC e6754f62-e3b2-773f-e053-2a95a90ad36a 2024-12-02 Warnings Exact identifier application number: M013 Pain Relief ACETAMINOPHEN AAA Pharmaceutical, Inc. a891896d-c9fa-4448-915a-e6b531157d22 2024-12-02 Warnings Exact identifier application number: M013 Pain Relief Extra Strength ACETAMINOPHEN SAFEWAY d2d15e06-e9eb-3d2b-e053-2995a90a1cec 2024-12-02 Warnings Exact identifier application number: M013 Pain Relief Regular Strength ACETAMINOPHEN TopCo Associates LLC c2d33352-431c-4683-a4fa-a54437e7b8d2 2024-12-02 Warnings Exact identifier application number: M013 Pain Relief Extra Strength ACETAMINOPHEN TopCo Associates LLC bdb01b3e-ad34-4003-9b9a-e83a2c0e90bb 2024-12-02 Warnings Exact identifier application number: M013 Aspirin 81mg Adult Low Dose ASPIRIN TopCare 14d010fb-c4a1-4c3d-942f-58719727bfc0 2024-12-02 Warnings Exact identifier application number: M013 Acetaminophen ACETAMINOPHEN CVS Pharmacy, Inc c4473ee6-4e01-1ec2-e053-2995a90ac513 2024-12-02 Warnings Exact identifier application number: M013 Aspirin ASPIRIN Proficient Rx LP 9c186289-e309-45e8-8934-1d0eae0375c2 2024-12-01 Warnings Exact identifier application number: M013 Childrens Chewable Acetaminophen ACETAMINOPHEN GERI-CARE PHARMACEUTICAL CORP 22f63d62-c941-5b8f-e063-6394a90aeecd 2024-11-28 Warnings Exact identifier application number: M013 Extra Strength Acetaminophen ACETAMINOPHEN Geri-Care Pharmaceutical Corp 7a7b6318-b7d6-31b1-e053-2991aa0abf25 2024-11-28 Warnings Exact identifier application number: M013 Extra Strength Pain Reliever PM ACETAMINOPHEN, DIPHENHYDRAMINE HCL INGLES MARKETS, INC. 27fd288e-c07a-617f-e063-6394a90a17a4 2024-11-28 Warnings Exact identifier application number: M013 BAYER Aspirin Original, TRAVEL BASIX ASPIRIN Lil' Drug Store Products, Inc. 7f5d9ebe-8119-49a2-9380-eca18a5e5e85 2024-11-27 Warnings Exact identifier application number: M013 EXCEDRIN MIGRAINE ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE Jones Healthcare Group - Packaging Services, Inc c4168e4d-3dfc-4e51-a32e-14704cb59c66 2024-11-27 Warnings Exact identifier application number: M013 TYLENOL Extra Strength / TYLENOL Precise Cooling Pain Relief ACETAMINOPHEN, LIDOCAINE, MENTHOL Kenvue Brands LLC 2611e984-0dd5-bda1-e063-6394a90a559a 2024-11-26 Warnings Exact identifier application number: M013 First Aid Only Extra-Strength Non-Aspirin ACETAMINOPHEN Acme United Corporation 6891d57a-10a6-53de-e053-2a91aa0ac7c2 2024-11-26 Warnings Exact identifier application number: M013 Chewable Aspirin ASPIRIN MARC GLASSMAN, INC. c8314910-71ff-5a55-e053-2995a90aafc7 2024-11-26 Warnings Exact identifier application number: M013 Aspirin ASPIRIN Marc Glassman, Inc. 7990ca49-fb30-40fe-9ac4-48e89eac9bb2 2024-11-26 Warnings Exact identifier application number: M013 Enteric Coated Aspirin Regular Strength ASPIRIN Safeway 96359eb6-62bc-4b13-960c-050af99a8c02 2024-11-26 Warnings Exact identifier application number: M013 ASPIRIN Low Dose ASPIRIN Marc Glassman, Inc. 3d519af3-9398-4439-8253-1e5d4612b8e3 2024-11-26 Warnings Exact identifier application number: M013 ACETAMINOPHEN (RED) ACETAMINOPHEN Humanwell PuraCap Pharmaceutical (Wuhan), Ltd. 06eabf4b-f8c0-439a-acf1-aa6e3075c717 2024-11-25 Warnings Exact identifier application number: M013
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 71687-3003-1 71687300301 1 BOTTLE, PLASTIC in 1 CARTON (71687-3003-1) / 20 TABLET in 1 BOTTLE, PLASTIC 2016-06-01 0000-00-00 No No Current 71687-3003-4 71687300304 1 BOTTLE, PLASTIC in 1 CARTON (71687-3003-4) / 40 TABLET in 1 BOTTLE, PLASTIC 2016-06-01 0000-00-00 No No Current